Authors
Fateme Rezvani Dehaghani, Sogand Kasgari Saadat, Nabaa Najjar, Fatemeh Javani Jouni, Jaber Zafari
Published in
Molecular biology reports. Volume 53. Issue 1. Nov 15, 2026. Epub Nov 15, 2026.
Abstract
Photodynamic therapy (PDT) is a minimally invasive method for cancer treatment based on the triad of a photosensitizing agent (PS), an appropriate wavelength of light, and tissue oxygen, which works by producing reactive oxygen species (especially singlet oxygen,[Formula: see text]). However, rapid photochemical oxygen consumption during PDT, combined with ongoing oxygen utilization by mitochondrial respiration, can exacerbate local hypoxia and compromise singlet oxygen generation in solid tumors. In this review study, we examine the relationship between mitochondrial metabolism (OXPHOS and the electron transport chain), oxygen consumption, and the efficacy of PDT. We also discuss the metabolic flexibility of cancer cells (the shift between the Warburg effect and oxidative phosphorylation) and the impact of the hypoxia axis (HIF-1/2α) on treatment resistance. So far, strategies such as mitochondrial respiration inhibition, mitochondria-targeted nanoplatforms, and redox manipulation have been implemented to address this issue. Reprogramming mitochondrial metabolism along with smart drug delivery systems is considered a promising approach to overcoming hypoxia and achieving personalized treatments in PDT, although proving the clinical efficacy of these strategies will require more extensive experimental studies and trials in the future.
PMID:
43034950
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0